Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy INVO Bioscience stock

Learn how to easily invest in INVO Bioscience stock.

INVO Bioscience is a medical devices business based in the US. INVO Bioscience shares (INVO) are listed on the NASDAQ and all prices are listed in US Dollars. INVO Bioscience employs 15 staff and has a trailing 12-month revenue of around $1.2 million.

How to buy INVO Bioscience stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – INVO. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 in stock when you fund a new account within 30 days

Promoted for social trading

Finder Award


  • Easy to use platform with $0 stock trading & no annual fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100

Promoted for active trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

INVO Bioscience stock price (NASDAQ: INVO)

Use our graph to track the performance of INVO stocks over time.

INVO Bioscience shares at a glance

Information last updated 2023-09-17.
Latest market close$1.01
52-week range$0.92 - $29.60
50-day moving average $2.86
200-day moving average $8.64
Wall St. target price$20.00
PE ratio 0.0595
Dividend yield $0 (0%)
Earnings per share (TTM) $25.36

Buy INVO Bioscience stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 7 of 7
Name Product Ratings Available asset types Minimum deposit Signup bonus
SoFi Invest
Finder Rating: 4.6 / 5: ★★★★★

Finder Award
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000 in stock
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Rating: 4.2 / 5: ★★★★★

Finder Award
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Finder Rating: 4.1 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
Finder Rating: 4 / 5: ★★★★★
Stocks, ETFs, Cryptocurrency, Art, Treasury Bills, Collectibles
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
2.5% fee applies to all alternative asset transactions.
Finder Rating: 4.2 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4.9% interest on uninvested cash in your account with Robinhood Gold.
JPMorgan Self-Directed Investing
Finder Rating: 4 / 5: ★★★★★
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs, Treasury Bills
Get $50 - $700
when you open and fund an account with $5,000 - $250,000+
Pay no commissions on stocks, ETFs, mutual funds and options.
Finder Rating: 4 / 5: ★★★★★
Stocks, ETFs
Wealthfront builds a free financial plan for the life you want and automate your investments at a low cost.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy INVO Bioscience stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

INVO Bioscience price performance over time

Historical closes compared with the close of $1.01 from 2023-09-21

1 week (2023-09-15) -2.88%
1 month (2023-08-23) -34.42%
3 months (2023-06-23) 512.12%
6 months (2023-03-23) 53.73%
1 year (2022-09-23) -6.22%
2 years (2021-09-23) -69.21%
3 years (2020-09-23) 6.4
5 years (2018-09-21) 12.7904

Is INVO Bioscience stock undervalued or overvalued?

Valuing INVO Bioscience stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of INVO Bioscience's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

INVO Bioscience's P/E ratio

INVO Bioscience's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, INVO Bioscience shares trade at around 0x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

However, INVO Bioscience's P/E ratio is best considered in relation to those of others within the medical devices industry or those of similar companies.

INVO Bioscience financials

Revenue TTM $1.2 million
Gross profit TTM $535,273
Return on assets TTM -92.01%
Return on equity TTM -1224.53%
Profit margin 0%
Book value $-2.06
Market Capitalization $3.7 million

TTM: trailing 12 months

INVO Bioscience share dividends

We're not expecting INVO Bioscience to pay a dividend over the next 12 months.

You may also wish to consider:

Have INVO Bioscience's shares ever split?

INVO Bioscience's shares were split on a 1:20 basis on 28 July 2023. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your INVO Bioscience shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for INVO Bioscience shares which in turn could have impacted INVO Bioscience's share price.

INVO Bioscience share price volatility

Over the last 12 months, INVO Bioscience's shares have ranged in value from as little as $0.92 up to $29.598. A popular way to gauge a stock's volatility is its "beta".

INVO.US volatility(beta: 1.18)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while INVO Bioscience's is 1.1773. This would suggest that INVO Bioscience's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

To put INVO Bioscience's beta into context you can compare it against those of similar companies.

INVO Bioscience overview

INVO Bioscience, Inc. , a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. INVO Bioscience, Inc. was founded in 2007 and is based in Sarasota, Florida. .

Frequently asked questions

What percentage of INVO Bioscience is owned by insiders or institutions?
Currently 4.773% of INVO Bioscience shares are held by insiders and 14.68% by institutions.
How many people work for INVO Bioscience?
Latest data suggests 15 work at INVO Bioscience.
When does the fiscal year end for INVO Bioscience?
INVO Bioscience's fiscal year ends in December.
Where is INVO Bioscience based?
INVO Bioscience's address is: 5582 Broadcast Court, Sarasota, FL, United States, 34240
What is INVO Bioscience's ISIN number?
INVO Bioscience's international securities identification number is: US44984F3029

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site